Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty
Filter
Applied FilterClear all
TargetMol | Tags By Target
  • Integrin
    (6)
  • ATPase
    (1)
  • Autophagy
    (1)
  • Others
    (25)
Filter
Search Result
Results for "

iib/iiia

" in TargetMol Product Catalog
  • Inhibitors & Agonists
    34
    TargetMol | Inhibitors_Agonists
  • Peptide Products
    7
    TargetMol | Peptide_Products
  • Inhibitory Antibodies
    1
    TargetMol | Inhibitory_Antibodies
  • Natural Products
    1
    TargetMol | Natural_Products
  • Recombinant Protein
    1
    TargetMol | Recombinant_Protein
  • Antibody Products
    2
    TargetMol | Antibody_Products
Tirofiban hydrochloride monohydrate
MK-383 Hydrochloride monohydrate, Tirofiban Hydrochloride monohydrate
T2537150915-40-5
Tirofiban(MK383) hydrochloride monohydrate is a non-peptide glycoprotein IIb IIIa antagonist.
  • Inquiry Price
Size
QTY
TargetMol | Inhibitor Hot
Roxifiban acetate
DMP-754 acetate, DMP 754 acetate, DMP 755, DMP754 acetate, MK 0853 acetate
T24733176022-59-6In house
Roxifiban acetate(DMP 754 acetate) is a potent GP IIb IIIa antagonist that exhibits antiplatelet aggregation activity via immune mediation and can be used in the study of human thrombocytopenia.
  • Inquiry Price
8-10 weeks
Size
QTY
Lefradafiban
BIBU 104, BIBU104, BIBU-104
T27808149503-79-7In house
Lefradafiban(BIBU-104) is an oral platelet glycoprotein IIb IIIa receptor antagonist for the study of angina pectoris and acute coronary syndromes.
  • Inquiry Price
6-8weeks
Size
QTY
TargetMol | Inhibitor Sale
Orbofiban
T61345163250-90-6In house
Orbofiban, an orally administered antagonist of the platelet GPIIb IIIa receptor, effectively inhibits platelet aggregation.
  • Inquiry Price
1-2 weeks
Size
QTY
Gantofiban
T68078183547-57-1In house
Gantofiban is a glycoprotein IIb IIIa (GP IIb IIIa) antagonist used in the treatment of cardiovascular disease and may be used to study thrombosis.
  • Inquiry Price
Size
QTY
TargetMol | Inhibitor Sale
roxifiban
DMP-754,DMP754,DMP 754
T24732170902-47-3In house
Roxifiban, a prodrug of XV459, is an antiplatelet agent with high affinity and specificity for platelet glycoprotein IIb/IIIa complex(GPIIb/IIIa) receptors.
  • Inquiry Price
1-2 weeks
Size
QTY
Fradafiban
BIBU-52
T11322148396-36-5
Fradafiban binds to the human platelet GP IIb IIIa complex with a Kd value of 148 nM. Fradafiban is a non-polypeptide platelet glycoprotein IIb IIIa antagonist.
  • Inquiry Price
10-14 weeks
Size
QTY
SR121566A
T12999180144-61-0
SR121566A is a novel non-peptide antagonist of Glycoprotein IIb IIIa (GP IIb-IIIa).
  • Inquiry Price
10-14 weeks
Size
QTY
Tirofiban HCl
Tirofiban hydrochloride, MK-383, MK383, MK 383, Aggrastat
T20552142373-60-2
Tirofiban HCl is an antagonist of platelet glycoprotein-IIb IIIa receptor.
  • Inquiry Price
Size
QTY
GR 144053 trihydrochloride
T228071215333-48-4
platelet fibrinogen receptor glycoprotein IIb/IIIa (GpIIb/IIIa) antagonist
  • Inquiry Price
6-8 weeks
Size
QTY
DMP 728
XL-118, XL118, XL 118, DMP-728, DMP728
T24009155158-97-7
DMP 728 is an antagonist of Glycoprotein IIb-IIIa.
  • Inquiry Price
3-6 months
Size
QTY
MK 0852
MK-0852,L-367,073,MK0852,L 367,073,L367,073
T24474138199-64-1
MK 0852 is the platelet GP IIb/IIIa cyclic heptapeptide antagonist.
  • Inquiry Price
Size
QTY
SK&F 107260
Skf107260,Skf-107260,Skf 107260
T24796136620-00-3
SK&F 107260 is an RGD-containing peptide. It is a potent GP IIb/IIIa antagonist and a vitronectin antagonist.
  • Inquiry Price
Size
QTY
Lamifiban
Ro-44-9883 000,Ro 44-9883 000,Ro44-9883 000
T25607144412-49-7
Lamifiban is a nonpeptide glycoprotein IIb/IIIa antagonist. It prevents platelet loss during experimental cardiopulmonary bypass.
  • Inquiry Price
Size
QTY
SK&F 106760
SKF-106760, SKF106760, SKF 106760, SK&, F-106760, F106760, F 106760
T26190126053-71-2
SKF 106760 is used as a glycoprotein IIb IIIa antagonist.
  • Inquiry Price
6-8 weeks
Size
QTY
AR-H067637
T26657433937-74-7
AR-H067637 is a rapid-binding, reversible and potent (inhibition constant K(i) = 2-4 nM), competitive inhibitor of thrombin, as well as of thrombin bound to fibrin (clot-bound thrombin) or to thrombomodulin. The total amount of free thrombin generated in
  • Inquiry Price
10-14 weeks
Size
QTY
Batifiban
T26739710312-77-9
Batifiban, a glycoprotein IIb/IIIa antagonist, is used potentially for the treatment of coronary artery disease.
  • Inquiry Price
Size
QTY
GPRP
Gly-Pro-Arg-Pro Acetate salt, Gly-Pro-Arg-Pro Acetate
T2741967869-62-9
GPRP (Gly-Pro-Arg-Pro) is a fibrin polymerization inhibitor that inhibits the interaction between fibrinogen and the platelet membrane glycoprotein IIb IIIa complex (glycoprotein IIb IIIa receptor).
  • Inquiry Price
7-10 days
Size
QTY
Lotrafiban hydrochloride
SB 214857a,Lotrafiban HCl,SB-214857-A
T27846179599-82-7
Lotrafiban hydrochloride is an platelet glycoprotein IIb/IIIa blocker with oral activity.
  • Inquiry Price
8-10 weeks
Size
QTY
Sibrafiban
RO-48-3657 001,RO-48-3657,RO 48-3657 001
T28775172927-65-0
Sibrafiban (RO 48-3657), an orally active, nonpeptide double-prodrug of Ro 44-3888, is a selective glycoprotein IIb IIIa receptor antagonist that inhibits platelet aggregation [1] [2] [3].
  • Inquiry Price
6-8 weeks
Size
QTY
TAK 029
TAK-029,TAK029
T28913176655-58-6
TAK 029 is a local glycoprotein IIb/IIIa receptor inhibitor.
  • Inquiry Price
8-10 weeks
Size
QTY
Eptifibatide
Mpr-Har-Gly-Asp-Trp-Pro-Cys-NH2
T5020148031-34-9
Eptifibatide (Eptifibatide Acetate), an antiplatelet drug of the glycoprotein IIb IIIa inhibitor class, is a cyclic heptapeptide constructed from 6 amino acids and a mercaptopropionyl residue.
  • Inquiry Price
Size
QTY
Eptifibatide acetate (148031-34-9 free base)
Eptifibatide acetate
T5146881997-86-0
Eptifibatide acetate (148031-34-9 free base) (Eptifibatide acetate) , an antiplatelet drug of the glycoprotein IIb IIIa inhibitor class, is a cyclic heptapeptide constructed from 6 amino acids and a mercaptopropionyl residue.
  • Inquiry Price
Size
QTY
Collagen-IN-1
T60303104260-73-3
Collagen-IN-1 (compound 3) is an ortho-carbonyl hydroquinone derivative that selectively inhibits collagen. It non-competitively inhibits agonist-induced platelet aggregation, with an IC50 value of 1.77 μM. Collagen-IN-1 reduces P-selectin expression, glycoprotein IIb IIIa activation, and the release of adenosine triphosphate and CD63 from platelets. This compound is promising for research into platelet-related thrombosis diseases [1].
  • Inquiry Price
6-8 weeks
Size
QTY